[
  {
    "ts": null,
    "headline": "Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025",
    "summary": "Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued carePresentations on tau to explore its biological role, the development of targeted therapies and biomarkers, and the future integration of these innovations into clinical practice CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International C",
    "url": "https://finnhub.io/api/news?id=7a9ca2b41e22a17139f587bab2d7e352e3b5e8cc659aaebea1b1b5747696153b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753140600,
      "headline": "Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025",
      "id": 136032233,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued carePresentations on tau to explore its biological role, the development of targeted therapies and biomarkers, and the future integration of these innovations into clinical practice CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International C",
      "url": "https://finnhub.io/api/news?id=7a9ca2b41e22a17139f587bab2d7e352e3b5e8cc659aaebea1b1b5747696153b"
    }
  },
  {
    "ts": null,
    "headline": "Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome",
    "summary": "We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Biogen Inc. stands sixth on our list among the most undervalued stocks. Biogen Inc. (NASDAQ:BIIB) is a global biotechnology leader known for its treatments in multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer’s disease, and an expanding portfolio in rare and pediatric neurological disorders. […]",
    "url": "https://finnhub.io/api/news?id=392487763cbb441dc3edf9abc1ccbd2a02e692bb902b844834b30cf94f8ac275",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753137080,
      "headline": "Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome",
      "id": 136032234,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Biogen Inc. stands sixth on our list among the most undervalued stocks. Biogen Inc. (NASDAQ:BIIB) is a global biotechnology leader known for its treatments in multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer’s disease, and an expanding portfolio in rare and pediatric neurological disorders. […]",
      "url": "https://finnhub.io/api/news?id=392487763cbb441dc3edf9abc1ccbd2a02e692bb902b844834b30cf94f8ac275"
    }
  },
  {
    "ts": null,
    "headline": "Biogen (BIIB) Stock Trades Down, Here Is Why",
    "summary": "Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock, citing concerns over the company's growth prospects and high-risk pipeline. The brokerage lowered its rating on the drugmaker to \"hold\" from \"buy\" and significantly cut its price target to $142 from $199. Truist expressed a lack of optimism regarding Biogen's Alzheimer's drug opportunity, forecasting only modest growth for Leqembi. The downgrade also pointed to weak grow",
    "url": "https://finnhub.io/api/news?id=e3c2208f4e9a02fae52c8ae36a5034d6bf74feac0044713062d9eaa06ad2c69c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753126260,
      "headline": "Biogen (BIIB) Stock Trades Down, Here Is Why",
      "id": 136031888,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock, citing concerns over the company's growth prospects and high-risk pipeline. The brokerage lowered its rating on the drugmaker to \"hold\" from \"buy\" and significantly cut its price target to $142 from $199. Truist expressed a lack of optimism regarding Biogen's Alzheimer's drug opportunity, forecasting only modest growth for Leqembi. The downgrade also pointed to weak grow",
      "url": "https://finnhub.io/api/news?id=e3c2208f4e9a02fae52c8ae36a5034d6bf74feac0044713062d9eaa06ad2c69c"
    }
  },
  {
    "ts": null,
    "headline": "Biogen beefs up North Carolina manufacturing ahead of potential Trump tariff",
    "summary": "Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S. amid President Donald Trump's tariff threats.",
    "url": "https://finnhub.io/api/news?id=280181c4f9719d53d757ae65a3684aa1e84c2d6c46df4ffcd907c6140f078a07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753118042,
      "headline": "Biogen beefs up North Carolina manufacturing ahead of potential Trump tariff",
      "id": 136032236,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S. amid President Donald Trump's tariff threats.",
      "url": "https://finnhub.io/api/news?id=280181c4f9719d53d757ae65a3684aa1e84c2d6c46df4ffcd907c6140f078a07"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Nasdaq Scale New Highs in Broad-Based Rally",
    "summary": "US equity indexes advanced in a broad-based rally, with two of the three mainstream indexes hitting",
    "url": "https://finnhub.io/api/news?id=8b4506c141a42cf6c49d90105e1d5e82cf0c5497e3d68c40b82c7358a4ee52fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753117892,
      "headline": "S&P 500, Nasdaq Scale New Highs in Broad-Based Rally",
      "id": 136032237,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "US equity indexes advanced in a broad-based rally, with two of the three mainstream indexes hitting",
      "url": "https://finnhub.io/api/news?id=8b4506c141a42cf6c49d90105e1d5e82cf0c5497e3d68c40b82c7358a4ee52fb"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 and Nasdaq 100 Jump to Record Highs as Bond Yields Fall",
    "summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.72%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures...",
    "url": "https://finnhub.io/api/news?id=bbcf22d811b4ae3ca79918fca7152914f40c9ea619da30b2491cc67b39013cdb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753111618,
      "headline": "S&P 500 and Nasdaq 100 Jump to Record Highs as Bond Yields Fall",
      "id": 136025478,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.72%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures...",
      "url": "https://finnhub.io/api/news?id=bbcf22d811b4ae3ca79918fca7152914f40c9ea619da30b2491cc67b39013cdb"
    }
  },
  {
    "ts": null,
    "headline": "Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls",
    "summary": "Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=7aa121e17d80f8a6f5228117c635ea3e46ae3fab696e4323fb201027e46a50c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753105230,
      "headline": "Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls",
      "id": 136025523,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=7aa121e17d80f8a6f5228117c635ea3e46ae3fab696e4323fb201027e46a50c8"
    }
  },
  {
    "ts": null,
    "headline": "Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm",
    "summary": "Biogen joins major drugmakers such as Eli  Lilly, Roche and Merck, who have all announced investments in the U.S. as the industry braces for potential import levies.  Drugs have so far been exempt from Trump's reciprocal tariffs, but he has often argued that separate levies are needed to bolster domestic manufacturing and avoid relying on other countries for medicine supply.  Earlier this month, Trump said the tariffs may be delayed, but could be as high as 200%.",
    "url": "https://finnhub.io/api/news?id=938367485f95d02b2dad4104e740a99fbe075f769bb7c30dcf9509fb11612434",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753098092,
      "headline": "Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm",
      "id": 136025390,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Biogen joins major drugmakers such as Eli  Lilly, Roche and Merck, who have all announced investments in the U.S. as the industry braces for potential import levies.  Drugs have so far been exempt from Trump's reciprocal tariffs, but he has often argued that separate levies are needed to bolster domestic manufacturing and avoid relying on other countries for medicine supply.  Earlier this month, Trump said the tariffs may be delayed, but could be as high as 200%.",
      "url": "https://finnhub.io/api/news?id=938367485f95d02b2dad4104e740a99fbe075f769bb7c30dcf9509fb11612434"
    }
  },
  {
    "ts": null,
    "headline": "Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary",
    "summary": "Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – today announced it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP). Since breaking ground in 1995, Biogen’s manufacturing in RTP has played a vital role in delivering the company’s pipeline and portfolio of in",
    "url": "https://finnhub.io/api/news?id=73782963a262645b30a89330afac3633825bbf9e6a88f48c8060bbeca69083f8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753097400,
      "headline": "Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary",
      "id": 136026035,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – today announced it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP). Since breaking ground in 1995, Biogen’s manufacturing in RTP has played a vital role in delivering the company’s pipeline and portfolio of in",
      "url": "https://finnhub.io/api/news?id=73782963a262645b30a89330afac3633825bbf9e6a88f48c8060bbeca69083f8"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: Competition Melts Away",
    "summary": "Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY.",
    "url": "https://finnhub.io/api/news?id=309600c6e7f1364dec625a415f7b6ae30fc3d7ed41de0faac8e568f7271fe5e9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753092000,
      "headline": "Eli Lilly: Competition Melts Away",
      "id": 136024949,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1418928072/image_1418928072.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY.",
      "url": "https://finnhub.io/api/news?id=309600c6e7f1364dec625a415f7b6ae30fc3d7ed41de0faac8e568f7271fe5e9"
    }
  },
  {
    "ts": null,
    "headline": "Biogen to Invest Additional $2 Billion in North Carolina Research Hub",
    "summary": "Biogen to Invest Additional $2 Billion in North Carolina Research Hub",
    "url": "https://finnhub.io/api/news?id=0266ce23a267f6fc8c51e3bea16c0f3f8971cc13e888716633dc3a976a0fc9e5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753084680,
      "headline": "Biogen to Invest Additional $2 Billion in North Carolina Research Hub",
      "id": 136229896,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen to Invest Additional $2 Billion in North Carolina Research Hub",
      "url": "https://finnhub.io/api/news?id=0266ce23a267f6fc8c51e3bea16c0f3f8971cc13e888716633dc3a976a0fc9e5"
    }
  }
]